鼎龍股份(300054.SZ):現已佈局全製程CMP拋光液產品,型號基本全面覆蓋下游晶圓廠客户使用需求
格隆匯11月22日丨鼎龍股份(300054.SZ)於近期接受特定對象調研,就“公司CMP拋光液業務推進情況怎樣?”,公司回覆稱,公司現已佈局全製程CMP拋光液產品,型號基本全面覆蓋下游晶圓廠客户使用需求,且具備送樣、批量銷售能力。目前,公司已有介電材料拋光液、以自產氧化鋁研磨粒子為基礎的金屬拋光液、鎢拋光液、大硅片拋光液、多晶硅製程等多款拋光液產品在客户端銷售,其餘製程CMP拋光液產品在客户端持續驗證中,部分型號有望在第四季度成功導入。此外,鼎龍(仙桃)半導體材料產業園擴產項目:年產1萬噸CMP拋光液一期及年產1萬噸CMP拋光液用配套納米研磨粒子已於11月全面竣工,年內開始試生產供應,為CMP拋光液產品後續配合市場需求加速放量奠定基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.